News

ALS Limited (ASX Code: ALQ) advises that Mr Raj Naran will be the Company’s next CEO and Managing Director, succeeding Greg Kilmister who will retire from the Company at the conclusion of the 2017 Annual General Meeting on July 20 after 36 years with the Company, including 12 years as CEO. Read More

This festive season ALS is getting behind the Queensland Gives Christmas Appeal which assists refugees and their families to establish a life in Queensland. Read More

ALS was honoured to receive the Recognition for Services to the Industry Award, and applauds the support provided to the resources sector in Australia by Mrs Rinehart, Executive Chairman of the Hancock Prospecting Group, and the Hancock Prospecting Group. Read More

ALS reports interim dividend 5.5 cents per share, significant Life Sciences acquisitions completed or in final stages and H2FY17 underlying profit expected to be $50 – 60 million. Read More

Read More

Read More

ALS is pleased to announce the acquisition of Maverick Testing Laboratories, Inc. and Mav-Tech, Inc. (Maverick). Maverick operates from laboratories in Houston and Corpus Christi, Texas and employs approximately forty people. Read More

Read More

ALS Limited has acquired a minority interest in TerraCore Inc., a provider of hyperspectral mineralogical imaging. Read More

Greg Kilmister – Managing Director, has presented the 2015 Full Year Results of ALS Limted. Read More